 Biotech stocks rebounded in the week ended March 6, recovering from the previous weeks steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccine news. View more earnings on IBBThe following are key catalysts in the unfolding week that a biotech 